CD1 proteins are a family of major histocompatibility complex (MHC) class I-like antigen-presenting molecules that present lipids to T cells. The cytoplasmic tails (CTs) of all human CD1 isoforms, with the exception of CD1a, contain tyrosine-based sorting motifs, responsible for the internalization of proteins by the clathrin-mediated pathway. The role of the CD1a CT, which does not possess any sorting motifs, as well as its mode of internalization are not known. We investigated the internalization and recycling pathways followed by CD1a and the role of its CT. We found that CD1a can be internalized by a clathrinand dynamin-independent pathway and that it follows a Rab22a-and ADP ribosylation factor (ARF)6-dependent recycling pathway, similar to other cargo internalized independent of clathrin. We also found that the CD1a CT is S-acylated. However, this posttranslational modification does not determine the rate of internalization or recycling of the protein or its localization to detergentresistant membrane microdomains (DRMs) where we found CD1a to be enriched. We also show that plasma membrane DRMs are essential for efficient CD1a-mediated antigen presentation. These findings place CD1a closer to MHC class I in its trafficking and potential antigen-loading compartments among CD1 isoforms. Furthermore, we identify CD1a as a new marker for the clathrin-and dynamin-independent and DRM-dependent pathway of internalization as well as the Rab22a-and ARF6-dependent recycling pathway.
CD1 proteins are a family of major histocompatibility complex (MHC) class I-like antigen-presenting molecules that present lipids to T cells. The cytoplasmic tails (CTs) of all human CD1 isoforms, with the exception of CD1a, contain tyrosine-based sorting motifs, responsible for the internalization of proteins by the clathrin-mediated pathway. The role of the CD1a CT, which does not possess any sorting motifs, as well as its mode of internalization are not known. We investigated the internalization and recycling pathways followed by CD1a and the role of its CT. We found that CD1a can be internalized by a clathrinand dynamin-independent pathway and that it follows a Rab22a-and ADP ribosylation factor (ARF)6-dependent recycling pathway, similar to other cargo internalized independent of clathrin. We also found that the CD1a CT is S-acylated. However, this posttranslational modification does not determine the rate of internalization or recycling of the protein or its localization to detergentresistant membrane microdomains (DRMs) where we found CD1a to be enriched. We also show that plasma membrane DRMs are essential for efficient CD1a-mediated antigen presentation. These findings place CD1a closer to MHC class I in its trafficking and potential antigen-loading compartments among CD1 isoforms. Furthermore, we identify CD1a as a new marker for the clathrin-and dynamin-independent and DRM-dependent pathway of internalization as well as the Rab22a-and ARF6-dependent recycling pathway.
Key words: CD1, clathrin, cytoplasmic tail, dynamin, internalization, MHC class I, recycling, S-acylation CD1 proteins are a family of glycosylated molecules that present self and foreign lipid antigens to T cells. In humans, this family of proteins can be divided according to sequence and functional criteria into group 1 -CD1a, CD1b and CD1c; group 2 that includes CD1d and, finally, group 3 that includes CD1e. CD1 molecules share sequence and structural homology with major histocompatibility complex (MHC) class I and are thought to have evolved from classical MHC class I by gene duplication and neofunctionalization early in vertebrate evolution (1) . Similar to MHC class I, CD1 molecules are heterodimers comprised of a heavy chain that includes three extracellular domains (a1, a2 and a3), followed by a transmembrane domain and a short cytoplasmic tail (CT). The heavy chain is non-covalently bound to beta 2-microglobulin (b 2 m) light chain. However, the antigen-binding groove shows striking differences between CD1 molecules and MHC class I. The CD1 antigen-binding groove is deeper and narrower than MHC class I and the amino acids that line it are predominantly nonpolar, resulting in a hydrophobic antigenbinding channel [reviewed in 2] . This feature of CD1 results in binding of lipid, glycolipid and lipopeptide antigens that can then be presented to a T-cell receptor. In recent years, a variety of lipid antigens were found to be bound by CD1 molecules, such as diacylglycerols, polyketide lipids, sphingolipids, lipopeptides and mycobacterial lipids such as mycolic acids [reviewed in 3] . In addition, it has been shown that lipids with different chemical and physical properties traffic to different intracellular compartments. A study using lipid analogs that differed only in the length and unsaturations of the respective alkyl chains revealed that lipids with short or unsaturated alkyl chains traffic to the endocytic recycling compartment (ERC), while lipids with long and saturated tails are delivered to late endocytic compartments (4) . Indeed, glucose monomycolate, a microbial lipid antigen presented by CD1b, with long alkyl chains (C 80 ) preferentially accumulates in lysosomes when compared with an analog of the same antigen with shorter alkyl chains (C 32 ) (5).
CD1 molecules have been shown to follow different intracellular trafficking pathways [reviewed in 6]. For instance, CD1b prominently localizes to late endosomes and lysosomes, while CD1a does not traffic to late endocytic compartments, and CD1c and CD1d show a more promiscuous distribution within the endocytic pathway (7) . Therefore, CD1 is functionally similar to MHC class II in regard to the ability of both molecules to survey endocytic compartments and, specifically, late endosomes/lysosomes for antigen acquisition.
The CT of CD1 proteins has been shown to be critical for CD1 intracellular localization and its antigen-presenting function. The CTs of human CD1b, CD1c and CD1d, and also murine CD1d, all possess a tyrosine-based motif of the YXXf type in which Y is a tyrosine, X is any amino acid and f is a bulky hydrophobic residue. In contrast, CD1a does not contain any recognizable sorting motifs. The deletion of the CTs of CD1b and murine CD1d reduces or abolishes the internalization and trafficking of the respective proteins to late endocytic compartments (8) (9) (10) (11) (12) . Moreover, tail-deleted (TD) CD1b and CD1d mutants display an impaired antigen-presenting capacity (9, 11, 13) . In addition, some CD1 proteins possess putative dileucinebased sorting motifs (14) , although it has not been shown if these play any role in trafficking or function. Tyrosineand dileucine-based motifs are known to bind adaptor protein (AP) complexes, such as AP-2, which is involved in endocytosis [reviewed in 15] . In fact, human CD1b and CD1c and murine CD1d CTs have been shown to bind AP-2 or one of its subunits (8, 12) . This last finding implies that CD1b, CD1c and CD1d are internalized in an AP-2-dependent manner, a pathway that is also mediated by clathrin, which coats the endocytic vesicles, and dynamin, which is thought to be involved in membrane fission. Indeed, CD1b internalization has been shown to be dynamindependent (8) . Despite lacking any known sorting motifs in its CT, CD1a is internalized from the plasma membrane into endosomal compartments and recycles back to the plasma membrane through the ERC (7, 16) . It is not clear, however, if the CD1a CT determines the intracellular trafficking pathways followed by this molecule.
In this study, we investigated the internalization and recycling pathways followed by CD1a and the role of the CD1a CT. Our results suggest that CD1a and MHC class I follow similar trafficking pathways within the endocytic system.
Results
CD1a follows a clathrin-, AP-2-and dynaminindependent pathway of internalization CD1a was previously found in clathrin-coated pits and clathrin-coated vesicles (7, 16) . However, unlike other CD1 isoforms, CD1a does not possess a tyrosine-based motif or other known sorting motifs that can bind AP-2 and mediate clathrin-dependent internalization (Table 1) . Therefore, we investigated the pathway of internalization followed by CD1a. We first utilized a knockdown approach directed at the clathrin heavy chain (CHC) and the m2 subunit of AP-2 using small interfering RNA (siRNA). For this, HeLa cells stably expressing CD1a or CD1b were transfected with siRNA oligos and analyzed for the presence of CD1 on the surface by flow cytometry ( Figure 1A,B) . As a control, transferrin receptor (TfR), a molecule known to follow a clathrin-mediated pathway of internalization, was used. The TfR showed a marked increase in surface expression when either CHC or m2 were knocked down. Strikingly, CD1a surface expression did not show any changes, contrary to CD1b that is known to bind AP-2 and follow a clathrin-mediated internalization pathway ( Figure 1A ,B) (8) . We also disrupted the clathrin-mediated pathway by using a dominant-negative mutant of dynamin 2. HeLa cells stably transfected with CD1a or CD1b and transiently transfected with dynamin 2 K44A dominant-negative mutant expectedly showed an increase in TfR surface expression (Figure 1 C,D). In accordance with the results obtained with siRNA, the surface expression of CD1a did not show significant changes, while CD1b surface levels were upregulated. These results suggest that CD1a follows a clathrin-, AP-2-and dynamin-independent internalization pathway. The experiments directly measuring CD1a internalization in dynamin 2 K44A transfectants were not fully conclusive as they showed a small but nonsignificant reduction (data not shown).
Importantly, we also analyzed human immature monocytederived dendritic cells (DCs), which normally express all CD1 isoforms. We detected increased surface levels of TfR when AP-2 m2 was knocked down by short hairpin RNA (shRNA) transduction, whereas no increase in CD1a surface levels could be detected ( Figure 1E ). Moreover, we detected a decrease in CD1a surface expression, further suggesting that CD1a and TfR follow different pathways of internalization.
CD1a is S-acylated in the CT In a search of a possible role for the CD1a CT in internalization and trafficking of the molecule, we analyzed the presence of posttranslational modifications that can occur in the CT. Palmitoylation consists of the covalent attachment of a fatty acid (which can be palmitate or another fatty acid, hence the more appropriate designation S-acylation) to a cysteine. Contrary to myristoylation, another type of posttranslational lipid modification, there is no consensus sequence for S-acylation and it does not always occur at the N-terminus. Interestingly, CD1a possesses two cysteines in its CT (Table 1) , which is striking considering that it only has six residues in total. We therefore investigated if CD1a could be S-acylated by incubating HeLa:CD1a stable transfectants with radiolabeled palmitic acid, followed by lysis and immunoprecipitation of CD1a ( Figure 2) . As a control, we were able to detect labeled TfR, which is a known S-acylated protein. Strikingly, we also detected labeled CD1a, indicating that, indeed, CD1a is S-acylated. We predicted that, if CD1a is S-acylated in its CT, a truncation of the tail would abolish the lipid modification. Therefore, we generated HeLa cells that stably express a CD1a tail-truncated mutant, with no cytoplasmic cysteines (HeLa:CD1a TD; Table 1 ). Notably, we failed to detect labeled CD1a in HeLa:CD1a TD cells (Figure 2 ), indicating that CD1a is S-acylated on one or both cysteines of the CT.
CD1a partitions to detergent-resistant membrane microdomains, and these are necessary for efficient CD1a-restricted antigen presentation Many palmitoylated proteins, such as kinases and some Ga proteins (17) , are known to localize to detergent-resistant membrane microdomains (DRMs) or lipid rafts, which are domains enriched in cholesterol and sphingolipids [reviewed in 18] . Also, glycosyl-phosphatidylinositol-anchored proteins, which follow a nonclathrin, dynamin-independent pathway of internalization (19) , partition into DRM establishing a dynamin-independent and DRM-dependent pathway of internalization. During the preparation of this article, another study found that MHC class II invariant chain (Ii) can associate with a fraction of CD1a molecules in immature DCs and that this association is dependent on DRM integrity where CD1a is partially found (20) . Therefore, we investigated if CD1a partitions into DRM also in HeLa cells, which do not express Ii. We extracted the DRM by lysing HeLa:CD1a stable transfectants in cold Triton-X-100 and fractionating the lysate using a sucrose step gradient. Under these conditions, the DRMs float and can be isolated from other membranes. As shown in Figure 3A ,B, CD1a partitions together with a DRM marker, caveolin, concentrating specifically in fraction number 10. Nevertheless, most of the CD1a protein is detected in fractions that do not float (fractions numbers 1-4), although a significant amount of caveolin also partitions to these fractions. As a control, TfR, which is a non-DRM protein, is virtually undetectable in DRM-containing fractions ( Figure 3C ). These results suggest that, indeed, a fraction of the CD1a present in the cell is associated with DRM, independently of Ii.
To confirm that DRMs are important for CD1a-dependent antigen presentation, we tested the efficiency of presentation of a CD1a-dependent antigen in cholesteroldepleted immature monocyte-derived DCs. We treated DCs with methyl-b-cyclodextrin (MbCD), fixed the cells and incubated with dideoxymycobactin (DDM) and CD8-2 T cells (21) . We found a striking decrease in the efficiency of presentation of this antigen, which in these experimental conditions has to be surface loaded ( Figure 3E ). As a control, we saw that non-fixed cells, in which MbCD is washed away after treatment, do not present any defect in DDM presentation (data not shown). This indicates that the cells are not dead or functionally impaired after cholesterol depletion. These results suggest that plasma membrane DRMs are important for CD1a-restricted antigen presentation in DCs.
Tail-deleted CD1a localizes to DRM and shows normal trafficking and function Because CD1a was shown to partition to DRM and is S-acylated, we investigated if the CD1a TD mutant, which is not S-acylated, also partitions into DRM. Interestingly, we were able to detect this mutant in DRM fractions, suggesting that the S-acylation does not determine the partition of this protein into DRM ( Figure 3D ).
S-acylation of the CT of transmembrane proteins is known to influence their trafficking. For instance, S-acylation of one cysteine in the CT of the cation-dependent mannose 6-phosphate receptor is critical for the correct trafficking and function of this receptor (22) . We therefore investigated whether the trafficking of CD1a TD is altered compared with CD1a wild type (wt). We first studied the expression of CD1a TD on the cell surface. We analyzed by flow cytometry the levels of CD1a on the surface of transiently transfected HeLa cells and saw no apparent difference in the surface expression of CD1a TD mutant when compared with CD1a wt ( Figure 4A ). We also analyzed the 
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Traffic 2008; 9: 1446-1457 internalization and recycling rates of CD1a TD. Surprisingly, the CD1a internalization rate was relatively fast and reached equilibrium after 20 min ( Figure 4B ). This result was unexpected because CD1a does not have any sorting motif in its CT, like other CD1 isoforms that possess tyrosine-based motifs (Table 1) , and it is not internalized in a clathrin-dependent manner ( Figure 1) . Notably, when we compared the internalization rates of CD1a wt and CD1a TD, we saw no difference ( Figure 4B ). To study the recycling rates, we analyzed by flow cytometry the reappearance of CD1a on the cell surface after internalizing the protein bound to an antibody and stripping the antibody bound to non-internalized proteins. Similar to the internalization and surface expression studies, no differences between the recycling of CD1a wt and CD1a TD were detected ( Figure 4C ). Therefore, these results identified no differences in trafficking between CD1a wt and CD1a TD.
To confirm this, we compared the intracellular localization of CD1a wt and CD1a TD by transfecting these constructs into HeLa cells and performing confocal microscopy analysis. CD1a is known to recycle through the ERC without trafficking to late endocytic compartments (7) . Therefore, we used transferrin (Tf) ligand, which also recycles through the ERC, as a marker for this compartment. As shown in Figure 4D , CD1a wt displays punctate staining after internalization and accumulation in the perinuclear region where the ERC is localized. As expected, there is colocalization with Tf ( Figure 4F) . Similarly, CD1a TD shows perinuclear accumulation and colocalization with Tf (Figure 4I ), suggesting that there are no differences in trafficking after internalization between the two molecules at this level of resolution. Together, these results indicate that the S-acylation of the CD1a CT does not play a significant role in the internalization or recycling of the protein or its localization to DRM.
CD1a TD presents antigens efficiently to T cells All the assays described thus far failed to show any differences in localization and trafficking between CD1a wt and CD1a TD. However, differences below the detection level of our assay systems could still lead to functional defects. We therefore compared the ability of the CD1a TD to present the antigen sulfatide with specific CD1a-restricted T cells (23) and compared this with CD1a wt. As shown in Figure 5 , when transfected HeLa cells were pulsed with sulfatide antigen, recognition by CD1a-restricted, sulfatide-specific T cells revealed no significant difference between CD1a wt and CD1a TD. This suggests that the CD1a CT does not appear to influence the antigenpresenting function of CD1a.
CD1a follows an ARF6-and Rab22a-dependent recycling pathway, similar to MHC class I As shown in Figure 1 , the CD1a internalization pathway differs from the one followed by cargo internalized in a clathrin-dependent manner, such as TfR. Recently, the small guanosine triphosphatase Rab22a was shown to be involved in the recycling of proteins that are not dependent on clathrin for internalization (24) . This recycling pathway, which can be distinguished from the classical slow recycling pathway followed by TfR, is inhibited by the expression of Rab22a constitutively active or dominant-negative mutants (24) . However, a different study found significant inhibition in the recycling of TfR by a Rab22a constitutively active mutant (25) . This disparity could be because of the difference in the species origin of Rab22a used (25) . We used the same constructs as used in the study of Weigert et al. (24) . in HeLa cells and saw striking colocalization between CD1a and Rab22a ( Figure 6D ) and CD1a and Rab22a-Q64L constitutively active mutant ( Figure 6H ) in the tubular structures that represent tubular recycling endosomes (24) , suggesting that CD1a follows a Rab22a-dependent recycling pathway. Importantly, TfR could not be detected in these tubular recycling endosomes ( Figure  6C ,F), consistent with the results obtained by Weigert et al. (24) . When we used a Rab22a dominant-negative mutant (Rab22a S22N), we detected a marked reduction in the CD1a recycling rate, strongly suggesting that CD1a follows a Rab22a-dependent recycling pathway (5.07-fold change in CD1a surface expression after 30 min in the control versus 2.43-fold change in cells transfected with the dominantnegative mutant Rab22a S22N). The residual recycling observed in the dominant-negative mutant could be because of an incomplete block of Rab22a-dependent recycling or the existence of an alternative recycling pathway.
Proteins of the CD1 family show similarity to MHC class I at the sequence and structural level. Interestingly, MHC class I also follows a clathrin-and dynamin-independent internalization pathway and a Rab22a-dependent recycling pathway (24, 26) , similar to what we observed with CD1a. Therefore, we determined if MHC class I and CD1a colocalize under steady-state conditions. As shown in Figure 7 , we observed striking colocalization between these two proteins, including in the perinuclear area. These data further suggest that CD1a and MHC class I follow similar intracellular trafficking pathways.
CD1a endosomal recycling has been shown to be ADP ribosylation factor (ARF)6-dependent (7). Interestingly, MHC class I is also a marker for this pathway (27) . We therefore made use of an ARF6 constitutively active mutant (ARF6-Q67L), which blocks membrane trafficking shortly after internalization and sequesters cargo that normally traffics through the ARF6-dependent endocytic recycling pathway (28), such as MHC class I. HeLa cells transfected with the ARF6-Q67L mutant showed typical enlarged vacuolar structures where MHC class I accumulated ( Figure 8A ). Strikingly, CD1a, but not TfR (which is internalized in a clathrin-dependent manner), accumulated in the same structures. As expected, CD1b, which is internalized in an AP-2-and dynamin-dependent manner (8), also could not be detected in these enlarged vacuolar structures ( Figure  S1 ). These results are in agreement with the finding that CD1a follows an AP-2-and dynamin-independent internalization pathway ( Figure 1 ) and strongly suggest that CD1a follows a similar recycling pathway to MHC class I. Furthermore, they indicate that these two proteins not only share structural similarities but also are similar in their intracellular trafficking.
Discussion
Most CTs from different CD1 isoforms across species have well-characterized tyrosine-based sorting motifs or, alternatively, putative dileucine-based sorting motifs (14) . Primate (including human) CD1a CTs are the shortest known with only three residues downstream of the three basic residues present in general in all CD1 proteins (14) (C. C. Dascher, Mt. Sinai School of Medicine, New York, unpublished data). We investigated possible lipid modifications of the cysteines of the CD1a CT and showed that the CD1a CT is S-acylated on one or both cysteines. Interestingly, we were also able to detect S-acylation of CD1c, which has a cysteine next to the third residue of the CT like CD1a, but not of CD1b, which does not have any cysteines in its CT (unpublished data) ( Table 1) . Protein S-acylation is known to be important for membrane targeting, localization to membrane microdomains, signaling and protein trafficking [reviewed in 29] . It is therefore surprising that the truncation of the last three residues of the CD1a CT did not affect trafficking, including the rate of internalization and recycling. This suggests that the pathway followed by CD1a does not require any specific motifs in the CT. In the absence of specific motifs to direct intracellular trafficking, the pathway followed by CD1a could represent what might be described as a default recycling pathway for cell surface proteins. Alternatively, CD1a could interact with an unknown protein that regulates its trafficking along the endocytic pathway. Furthermore, we did not detect any defects in the antigen-presenting capacity of CD1a TD compared with CD1a wt, suggesting that the S-acylation of the CD1a CT does not play a significant role in the function of the protein. However, CD1a has been shown to be capable of loading antigens on the cell surface (30) , which could mask changes in intracellular loading of antigens onto CD1a.
While this article was being submitted, another study found that MHC class II Ii associates with CD1a and may influence CD1a trafficking (20) . Our findings complement that study by examining directly the CD1a internalization and recycling pathway and the role of CD1a CT in a cell type that does not express Ii. Furthermore, we confirmed that CD1a localizes to DRMs in HeLa cells, but this was not dependent on the S-acylation of its CT. We also confirmed that cholesterol-depleted immature monocyte-derived DCs are less efficient in presenting a CD1a-dependent exogenous antigen (DDM) loaded on the cell surface. This suggests that plasma membrane DRMs are essential for CD1a-restricted antigen presentation in DCs and is in agreement with the published results (20) .
We found that CD1a and MHC class I follow similar intracellular trafficking pathways. Both molecules can be detected in the Rab22a-dependent recycling pathway and recycle in an ARF6-dependent manner, contrary to TfR and other cargo internalized in a clathrin-dependent fashion. Indeed, we show in HeLa cells and DCs that the internalization of CD1a is essentially clathrin, AP-2 and dynamin independent. The reduction in CD1a surface levels, seen only in DCs when the AP-2 m2 subunit was knocked down, was unexpected. One possibility is that DCs might upregulate clathrin-independent pathways of internalization, such as the one followed by CD1a, when the clathrinmediated pathway is blocked. Our study looked for the first time at the internalization of CD1a, and we were surprised to find that the kinetics was very fast reaching equilibrium after 20 min, a rate consistent with receptor-mediated internalization. This implies that the clathrin-independent pathway followed by CD1a mediates fast internalization, similar to the clathrin-dependent pathway.
It is generally accepted that CD1 evolved from a classical MHC class I ancestor early in vertebrate evolution (1) . In this context, CD1a could represent a more primordial CD1 isoform, when compared for example with CD1b, because it has a smaller antigen-binding groove and binds lipids with short alkyl chains (e.g. sulfatide) (23, 31) . It also can bind lipids on the surface of the cell, contrasting with CD1b, which can accommodate lipids with C 80 alkyl chains in its antigen-binding groove and can only load these long lipids in acidic compartments such as late endosomes and lysosomes (5, 30) . A model has been proposed where, after gene duplication, different CD1 isoforms acquired different trafficking patterns, which then led to changes in the antigen-binding groove, to accommodate lipids that were present in the newly surveyed intracellular compartments (32). Our results fit this model in the sense that CD1a shows a similar trafficking pattern to MHC class I. We and others recently reported the presence of two CD1 genes in chicken, which makes these the most ancient known so far (33, 34) . Interestingly, one of these proteins shows an intracellular distribution similar to human CD1a (D. C. B., M. B. B. and C. C. Dascher, unpublished data).
Therefore, our study describes another level of similarity between MHC class I and CD1a, namely their intracellular trafficking, and these molecules essentially identify an internalization and recycling pathway that is only partially characterized. Yet, this pathway may be followed by a number of cell surface molecules with important immunological functions.
Materials and Methods

Cell culture
Cell culture reagents were from GIBCO (Invitrogen). HeLa epithelial cell line was cultured in DMEM, 10% fetal calf serum heat inactivated, 100 U/mL penicillin G, 100 mg/mL streptomycin, 2 mM L-glutamine and 20 mM HEPES.
CD141 monocyte isolation
Peripheral blood mononuclear cells (PBMC) were isolated from buffy coat preparations from healthy human donors by overlaying them on a FicollPaque PLUS (GE Healthcare) cushion and spinning at 1 600 Â g for 20 min. After washing three times with PBS, CD14þ monocytes were positively selected from PBMC using CD14 microbeads (Miltenyi Biotec) according to the manufacturer's instructions.
Monocyte-derived DCs
Differentiation of CD14 þ monocytes into immature monocyte-derived DCs was carried out by culturing in 300 U/mL of granulocyte-macrophage colony-stimulating factor (GM-CSF) (Sargramostim; Immunex) and 200 U/mL of interleukin (IL)-4 (PeproTech) for 4 days in complete medium (RPMI, 10% fetal calf serum heat inactivated, 100 U/mL penicillin G, 100 mg/mL streptomycin, 2 mM L-glutamine, 20 mM HEPES, 1 mM sodium pyruvate, 55 mM 2-mercaptoethanol and essential and nonessential amino acids). The cytokines were replenished at day 2.
Antibody labeling
Monoclonal antibodies (mAbs) 10H3 (anti-CD1a) and W6/32 (anti-MHC class I) were conjugated to Alexa Fluor 488 or 546 using monoclonal antibody labeling kits (Invitrogen) according to the manufacturer's instructions. Complementary DNAs encoding human CD1a wt and CD1a TD (without the last three amino acids of the CT) were generated by polymerase chain reaction (PCR) using human CD1a in pSRa-neo ( 
Constructs and HeLa transfection
RNA-mediated interference
RNA interference of the CHC and the m subunits of the AP-2 complex was performed by using siRNA duplexes (Qiagen; target sequences GUG-GAUGCCUUUCGGGUCA for m2 and UCCAAUUCGAAGACCAAUU for CHC) or an AP-2 m2 subunit (NM_004068) directed shRNA, cloned into the lentiviral expression vector PLKO. 
Flow cytometry analysis
Transfected HeLa dells were washed with PBS and subsequently harvested with PBS and 5 mM ethylenediaminetetraacetic acid (EDTA) or 0.5% trypsin-EDTA (GIBCO; Invitrogen) and incubated at 378C. shRNAtransduced monocyte-derived DCs were collected, overlayed on a FicollPaque (GE Healthcare) cushion and spun to exclude dead cells. Primary antibodies 10H3 (anti-CD1a) and BCD1b3.2 (anti-CD1b) were added at a concentration of 10 mg/mL and anti-TfR clone 5E9 (ascites; American Type Culture Collection) at a dilution of 1:300. The cells were incubated on ice, washed and phycoerythrin-or fluorescein-conjugated secondary antimouse antibodies added. After incubating on ice, the cells were washed and analyzed using a three-color FACSCalibur or a FACScan flow cytometer (BD Biosciences).
Surface biotinylation
HeLa:CD1a stable transfectants were washed with ice-cold PBS and surface biotinylated on ice with 0.5 mg/mL of Sulfo-NHS-LC-biotin or Sulfo-NHS-SS-biotin (Pierce) in PBS (pH ¼ 8.0) and 20 mM HEPES for 40 min at 48C adding one volume of 1 mg/mL biotin after 20 min. The cells were washed twice with PBS and 100 mM glycine to quench the excess biotin.
Immunoprecipitation
Samples were precleared by incubation with protein G-Sepharose (GE Healthcare) and monoclonal isotype antibody control for 1 h at 48C. 
Palmitoylation assay
HeLa:CD1a stable transfectants ($60-80% confluent) in 10-cm dishes were labeled overnight with 250 mCi/mL palmitic acid [9, H] (PerkinElmer) in complete medium with 1 mM sodium pyruvate. After washing with ice-cold PBS, cells were lysed in RIPA buffer (50 mM Tris, pH ¼ 7.5; 150 mM NaCl; 1% Triton-X-100; 0.05% deoxycholic acid; 0.1% SDS and protease inhibitors) and the lysate spun for 10 min at 13 500 Â g at 48C. The supernatant was then saved and TfR and CD1a immunoprecipitated using 2 mg of the mAbs MEM-189 (Abcam) and 10H3, respectively. The immunoprecipitates were resuspended in SDS sample buffer (62.5 mM Tris, pH ¼ 6.8; 10% glycerol; 2% SDS; 0.025% bromophenol blue and 20 mM DTT), boiled for 5 min and analyzed by SDS-PAGE. The gel was then washed with dimethyl sulphoxide (DMSO) (2 Â 20 min), once with 2,5-diphenyloxazole (22.5% in DMSO) for 1 h and, finally, with water (2 Â 30 min). The gel was then dried and exposed to a pre-flashed (using a sensitize TM precalibrated flash from GE Healthcare) X-ray film.
Isolation of DRMs
HeLa:CD1a wt and HeLa:CD1a TD stable transfectants ($90% confluent) were washed with ice-cold PBS and surface biotinylated (using Sulfo-NHS-LC-biotin). Cells were then washed with TNE buffer (25 mM Tris, pH ¼ 7.4; 150 mM NaCl and 5 mM EDTA) and lysed in this buffer containing 1% Triton-X-100, 0.1 M sodium carbonate (pH ¼ 11) and protease inhibitors on ice. After passing the lysate several times through a 22-G needle, the lysates were mixed with one volume of 80% sucrose in TNE buffer (with protease inhibitors). A sucrose step gradient was made by overlaying 35 and 5% sucrose steps and the gradients centrifuged overnight at 100 000 Â g at 48C. One-milliliter fractions were then collected from the bottom and the final concentration of Triton-X-100 adjusted to 0.5% in the fractions corresponding to the 35 and 5% sucrose steps.
Internalization assay
Confluent or near-confluent HeLa:CD1a wt and HeLa:CD1a TD stable transfectants on 6-cm dishes were washed with ice-cold PBS and surface biotinylated with Sulfo-NHS-SS-biotin (Pierce) as described above. Cells were left to internalize surface proteins at 378C for different periods of time (time 0 min was left on ice), washed with ice-cold PBS and the surface biotin cleaved by incubation at 48C for 20 min with 10 mM of the reducing agent sodium 2-mercaptoethanesulfonate (MesNa) in 50 mM Tris (pH ¼ 8.6), 150 mM NaCl, 1 mM EDTA and 0.2% BSA. After this first incubation, 10% volume of 100 mM MesNa in same buffer was added, and after a further 20 min, 12.5% volume of 100 mM MesNa was added. The cells were incubated with 16% volume of 500 mM iodoacetamide to quench the reducing agent, then washed with ice-cold PBS and lysed in RIPA buffer with protease inhibitors.
CD1a enzyme-linked immunosorbent assay
Plates were coated with 5 mg/mL of 10H3 antibody (anti-CD1a), blocked with PBS, 0.05% Tween-20 and 5% skimmed milk and incubated with the lysates from the internalization assay. To detect the total CD1a protein, antib 2 m rabbit polyclonal antibody (Rockland; 0.8 mg/mL) was used. After incubating with HRP-conjugated anti-rabbit antibody (Jackson ImmunoResearch Laboratories, Inc.; 0.4 mg/mL), the detection was performed with 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) (30% w/v in 0.1 M citric acid, pH ¼ 4.35, with 1 Â 10 À3 volume H 2 O 2 ). To detect internalized CD1a, plates were incubated with alkaline phosphatase (AKP)-conjugated streptavidin (BD Biosciences; diluted 1:1000) after incubating with the lysates. The AKP was developed with p-nitrophenyl phosphate (pNPP; 1 mg/mL in Tris-buffered saline, pH ¼ 9.8, and 1 mM MgCl 2 ). The optical density (OD) at 405 nm was read in a plate reader (Molecular Devices).
Recycling assay
HeLa cells were transiently cotransfected with CD1a or EFGP-Rab22a S22N constructs and pEGFP-C1 (BD Biosciences) in six-well plates with Fugene 6 (Roche) according to the manufacturer's instructions, and 24 h later, cells were trypsinized, washed with complete medium, counted and 250 000 cells plated in each well of 96-well plates. Anti-CD1a mAb 10H3 (10 mg/mL) was then incubated with the cells on ice in complete medium for 30 min and the excess antibody washed with cold complete medium. Cells were left to internalize the antibody-CD1a complexes for 25-30 min at 378C and were then chilled on ice, washed with ice-cold PBS and the surface antibody stripped by washing for 1 min with stripping buffer (0.5% acetic acid, pH ¼ 3.0, and 0.5 M NaCl) at room temperature. The cells were then incubated for different periods of time at 378C with complete medium to allow for proteins to recycle (time 0 min was left on ice) and were then washed and processed for flow cytometry analysis.
Immunofluorescence staining
Cells were plated onto glass coverslips preincubated with serum and left adhering overnight. Cells were then either transfected with Fugene 6 (Roche) or processed for staining. Where internalized Tf was observed, cells were serum starved by incubation at 378C for 30 min in minimal medium and 0.5% BSA, then chilled on ice, washed once with the same medium (ice cold) and incubated with anti-CD1a mAb (10H3, 1 mg/mL) and/ or labeled Tf (Alexa Fluor 546 or Alexa Fluor 647 conjugated; Invitrogen; 10 mg/mL) for 30 min on ice. After washing three times with ice-cold medium, cells were incubated at 378C for 30-45 min for the internalization to occur. In the case of Tf internalization, labeled Tf was kept in the medium to saturate the recycling pathway. After washing with PBS, the surface antibody was stripped by washing for 1 min with stripping buffer (0.5% acetic acid, pH ¼ 3.0, and 0.5 M NaCl) at room temperature. Cells were then washed again with PBS, fixed in 3% paraformaldehyde in PBS for 15-20 min at room temperature, quenched with 50 mM NH 4 Cl in PBS and blocked/permeabilized with PBS, 0.5% BSA and 0.1% saponin for 15 min at room temperature. Primary and secondary antibodies (anti-mouse Alexa Fluor 488 and Alexa Fluor 546 conjugated; Invitrogen; 4 mg/mL and antimouse Cy5 conjugated; Jackson ImmunoResearch Laboratories, Inc.; 2.8 mg/mL) were incubated in the same buffer for 30 min at room temperature and washed five times after each incubation. Coverslips were finally mounted in mounting medium (15% w/v vinol 205, 33% v/v glycerol and 0.1% azide in PBS) and analyzed in a Nikon C-1 confocal microscope with EZ C1 software. Images were processed with ADOBE PHOTOSHOP CS v8.0 adjusting the levels of each channel up to a maximum threshold defined by the absence of signal in the negative controls.
